Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 11, 2001

View Archived Issues

IND submitted for oral interferon in HIV-related oral warts

Chiron in new tobramycin collaboration with Inhale; terminates agreement with AeroGen

Procyon enters cancer technology option agreement

Pioglitazone prevents profibrogenic responses in the liver

Pharmacia outlines plans and priorities for delivering growth

Patients with refractory or relapsed acute leukemia respond to weekly BMS-214662

ICL-670A is an effective and safe iron chelator in beta-thalassemia according to preliminary data

Apoptotic effects of HA-14-1 characterized in leukemia and lymphoid cells

Full analysis of phase II data confirm efficacy of BBR-2778 in advanced NHL

FK-463 safe in stem cell transplant recipients according to ASH presentation

Immunomodulatory thalidomide derivative as a potential new therapeutic option for multiple myeloma

AC-7739 possesses cytotoxic and proapoptotic effects in MDR leukemia cell lines

Cipralex approved in Sweden; European mutual recognition procedure initiated

Cureon and Oxagen enter gene validation collaboration

Ortho-Clinical Diagnostics and Caprion to develop vCJD diagnostic test

Selective nonsteroidal estrogen receptor modulators claimed in recent patent

Takeda synthesizes oxazole-based HER2 receptor tyrosine kinase inhibitors

New HDL-elevating compounds from AtheroGenics useful in cardiovascular disease therapy

Final results of Val-HeFT study of valsartan in heart failure

GSK-3 inhibitors and use in diabetes and other disorders

Pharmacia R&D team identifies antibacterial agents particularly useful in skin and eye infections

Production and use of p38 MAP kinase inhibitors with additional pharmacological activities

FDA strengthens warnings for droperidol

Bioglan announces scheduled launch of Solaraze Gel in the U.S.

Biora licenses rights to wound healing product to Molnlycke Health Care

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...